The global pharmaceutical industry — a heavily regulated field with complex legal requirements – has experienced significant job growth during the past two decades. With the industry expected to continue to expand as AI increases the pace of drug development, law graduates with a background in science, and science graduates with an understanding of legal issues, will be well-positioned for a range of future careers.
Starting in fall 2025, Law and Biopharmaceutical Sciences, a new 20-unit interdisciplinary minor program combining the fields of law and biopharmaceutical sciences will be offered to USC undergraduate students.
Covering a range of topics including patent law, regulatory compliance, ethics and intellectual property, the program will be offered as a collaboration between the USC Mann School of Pharmacy and Pharmaceutical Sciences and the USC Gould School of Law.
